standard of care (SOC) for COVID-19

DRUG2 trials

Sponsors

King Hussein Cancer Center, Ministry of Health Jordan

Conditions

2019 Novel Coronavirus

Phase 1

The Potential Use of Inhaled Hydroxychloroquine for the Treatment of COVID-19 in Cancer Patients

WithdrawnNCT04731051

King Hussein Cancer Center2019 Novel Coronavirus

Start: 2022-10-31End: 2022-12-31Updated: 2023-04-07

Phase 2

The Potential Use of Nebulized Hydroxychloroquine for the Treatment of COVID-19

Ministry of Health Jordan2019 Novel Coronavirus

Start: 2022-03-20End: 2022-07-20Target: 110Updated: 2022-03-07